Zovirax Injection (Acyclovir Sodium) - News

News related to Zovirax Injection (Acyclovir) and/or conditions it is approved for

Epiphany Announces Positive Results From Its Phase 2b Trial In Shingles
Source: Clinical Trials / Drug Trials News From Medical News Today [2009.11.19]
Epiphany Biosciences announced results from its Phase 2b dose-ranging study of EPB-348 (valomaciclovir) in patients with shingles (herpes zoster) infection. The study's primary endpoint was non-inferiority of once-daily valomaciclovir compared to thrice-daily valacyclovir in terms of time to complete crusting of the shingles rash.